NAYA Biosciences | 10-Q: Q3 2024 Earnings Report

SECNov 20 05:22 · Announcements

NAYA Biosciences | 10-Q/A: Quarterly report (Amendment)

SECNov 20 05:17 · Announcements

NAYA Biosciences | 10-K/A: Annual report (Amendment)

SECNov 20 05:13 · Announcements

Express News | Naya Biosciences Inc - Receives Approval to Initiate NY-303 Clinical Trial in Israel

BreakingsOct 24 21:26

Express News | Naya Biosciences Announces Initiation of Phase 1/2a Clinical Trial for Its Gpc3-Targeted Nk Engager Bispecific Antibody in Patients With Hepatocellular Carcinoma

BreakingsOct 24 21:00

NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for Its GPC3-targeted NK Engager Bispecific Antibody in Patients With Hepatocellular Carcinoma

GlobeNewswireOct 24 21:00